Roubinian JR , Talal N., Greenspan JS, Goodman JR, Siiteri PKEffect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies and glomerulonephritis in NZB/NZW F, mice. J Exp Med1978; 147: 1568-83.
2.
Rothfield N.Clinical features of systemic lupus erythematosus. In: Textbook of Rheumatology. Kelley WN, Harris ED Jr, Ruddy S, Sledge CB (eds). Philadelphia: WB Saunders, 1985: 1070-97.
3.
Reeves WH, Lahita RGClinical presentation of systemic lupus erythematosus in the adult. In: Systemic Lupus Erythematosus. Lahita RG (ed.). New York: Churchill Livingstone, 1992: 369-96.
4.
Berczi I.The immunology of prolactin. Semin Reprod Endocrinol1992; 10: 196-219.
5.
Howie JB, Helyer BJThe immunology and pathology of NZB mice. Adv Immunol1968; 9: 215-66.
6.
McMurray R., Keisler D., Kanuckel K., Izui S., Walker SEProlactin influences autoimmune disease activity in the female B/W mouse. J Immunol1991; 147: 3780-7.
7.
Jara LJ, Gomez-Sanchez C., Silveria LH, Martinez-Osuna P., Vasey FB, Espinosa LRHyperprolactinemia in systemic lupus erythematosus: association with disease . Am J Med Sci303: 222-6.
8.
Jara-Quezada L., Graef A., Lavalle C.Prolactin and gonadal hormones during pregnancy in systemic lupus erythematosus. J Rheumatol1991; 18: 349-53.
9.
Lavalle C., Loyo E., Paniagua R. et al. Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus. J Rheumatol1987; 14: 268-72.
10.
McMurray RW , Allen SH, Braun AL, Rodriguez F., Walker SELongstanding hyperprolactinemia associated with systemic lupus erythematosus: possible hormonal stimulation of an autoimmune disease. J Rheumatol1994; 21: 843-50.
11.
McMurray RW , Weidensaul D., Allen SH, Walker SEEfficacy of bromocriptine (BRC) in an open label therapeutic trial for systemic lupus erythematosus (SLE). Arthritis Rheum1994; 37: S369 (abstract no. 1245).
12.
Tougard C., Tixier-Vidal A.Lactotropes and gonadotropes. In: The Physiology of Reproduction . Knobil E, Neill JD (eds). New York: Raven Press , 1988: 1305-33.
13.
Russell DHNew aspects of prolactin and immunity: a lymphocytedrived prolactin-like product and nuclear protein kinase C activation. Trends Pharmacol Sci1989; 10: 40-4.
14.
Yu-Lee LY, Stevens AM, Hrachovy JA, Schwartz LAProlactin-mediated regulation of gene transcription in lymphocytes. Ann NY Acad Sci1990; 594: 146-55.
15.
Thoreau E., Petridou B., Kelly PA, Djiane J., Mornon JPStructural symmetry of the extracellular domain of the cytokine/growth hormone/prolactin receptor family and interferon receptors revealed by hydrophobic cluster analysis . FEBS Lett1991; 282: 26-31.
16.
Kelly PA, Djiane J., Edery M.Different forms of the prolactin receptor. Insights into the mechanism of prolactin action. Trends Endocrinol Metab1992; 3: 54-9.
17.
Gagnerault M., Touraine P., Savino W., Kelly PA, Dardenne M.Expression of prolactin receptors in murine lymphoid cells in normal and autoimmune situations. J Immunol1993; 150: 5673-81.
18.
Russell DH, Kibler R., Matrisian L., Larson DF, Poulos B., Magun BEProlactin receptors on human T and B lymphocytes: antagonism of prolactin binding by cyclosporine. J Immunol1985; 134: 3027-31.
19.
Pellegrini I., Lebrun J., Ali S., Kelly PAExpression of prolactin and its receptor in human lymphoid cells. MolEndocrinol1992; 6: 1023-31.
20.
Dardenne M. , Kelly PA, Bach JF, Savino W.Identification and functional activity of prolactin receptors in thymic epithelial cells. Proc Natl Acad Sci USA1991; 88: 9700-4.
21.
Clevenger CV , Sillman AL, Hanley-Hyde J., Prystowsky MBRequirement for prolactin during cell cycle regulated gene expression in cloned T lymphocytes. Endocrinology1992; 130: 3216-22.
22.
Nagy E., Berczi I.Immunodeficiency in hypophysectomized rats. Acta Endocrinol (Copenh) 1978; 89: 530-7.
23.
Berczi I., Nagy E., Asa SL, Kovacs K.Pituitary hormones and contact sensitivity in rats. Allergy1983; 38: 325-30.
24.
Cross RJ, Campbell JL, Roszman TLPotentiation of antibody responsiveness after the transplantation of a syngeneic pituitary gland. J Neuroimmunol1989; 25: 29-35.
25.
Parkes D.Drug therapy: bromocriptine. New Engl J Med1979; 301: 873-8.
26.
Riskind PN, Massacesi L., Doolittle TH, Hauser SLThe role of prolactin in autoimmune demyelination: suppression of experimental allergic encephalomyelitis by bromocriptine. Ann Neurol1991; 29: 542-7.
27.
Berczi I., Nagy E., Asa SL, Kovacs K.The influence of pituitary hormones in adjuvant arthritis. Arthritis Rheum1984; 27: 682-8.
28.
Palestine AG , Nussenblatt RB, Gelato M.Therapy for autoimmune uveitis with low-dose cyclosporine plus bromocriptine. Transplant Proc1988; 20 (Suppl. 4): 131-5.
29.
Hedner LP, Bynke G.Endogenous iridocyclitis relieved during treatment with bromocriptine. Am J Ophthalmol1985; 100: 618-19.
30.
Andrews BS, Eisenberg RA, Theofilopoulos AN et al. Spontaneous murine lupus like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med1979; 148: 1198-215.
31.
McMurray R. , Keisler D., Izui S., Walker SEHyperprolactinemia in male NZB/NZW (B/W) F 1 mice: accelerated autoimmune disease with normal circulating testosterone . Clin Immunol Immunopathol1994; 71: 338-43.
32.
McMurray RW , Keisler D., Izui S., Walker SEEffects of parturition, suckling and pseudopregnancy on variables of disease activity in the B/W mouse model of systemic lupus erythematosus. J Rheumatol1993; 20: 1143-51.
33.
Adler RAThe anterior pituitary-grafted rat: a valid model of chronic hyperprolactinemia . Endocr Rev1986; 7: 302-13.
34.
Izui S., Lange G.Enzyme-linked immunosorbent assay for detection of retroviral gp70 and gp70-anti-gp70 immune complexes in sera from SLE mice. Clin Exp Immunol1988; 71: 45-9.
35.
McNeilly AS , Sharpe RM, Davidson DW, Fraser HMInhibition of gonadotropin secretion by induced hyperprolactinaemia in the male rat. J Endocrinol1978; 79: 59-68.
36.
Bartke A., Smith MS, Michael SD, Peron FG, Dalterio S.Effects of experimentally-induced chronic hyperprolactinemia on testosterone and gonadotropin levels in male rats and mice. Endocrinology1977; 100: 182-6.
37.
Smith MS, Freeman ME, Neill JDThe control of progesterone secretion during the estrous cycle and early pseudopregnancy in the rat: prolactin, gonadotropin and steroid levels associated with rescue of the corpus luteum of pseudopregnancy. Endocrinology1975; 96: 219-26.
38.
Smith MS, McLean BK, Neill JDProlactin: the initial luteotropic stimulus of pseudopregnancy in the rat . Endocrinology1976; 98: 1370-7.
39.
Folomeev M., Prokaeva T., Nassonova V., Nassonov E., Masenko V., Ovtraht N.Prolactin levels in men with SLE and RA. J Rheumatol1990; 17: 1569-70 (letter).
40.
Allen SH, Sharp GC, Conley C., Wang G., Walker SEAntibody profiles in hyperprolactinemic women with connective tissue disease . Arthritis Rheum1993; 36: S102 (abstract A26).
41.
Batrinos ML , Panitsa-Faflia C., Tsiganou E., Liapi C.Incidence and characteristics of microprolactinomas (3-5 mm) in 4199 women assayed for prolactin. Horm Metab Res1992; 24: 384-91.
42.
Miyai K., Ichihara K., Kondo K., Mori S.Asymptomatic hyperprolactinaemia and prolactinoma in the general population: mass screening by paired assays of serum prolactin. Clin Endocrinol1986; 25: 549-54.
43.
Costello RTSubclinical adenoma of the pituitary gland. Am J Pathol1936; 12: 205-15.
Ambrosi B., Faglia G., Multicenter Pituitary Tumor Study Group, Lombardia Region. Epidemiology of pituitary tumors. In: Pituitary Adenomas: New Trends in Basic and Clinical Research. Faglia G, Beck-Peccoz P, Amb rosi B , Travagl ini P, Spada A (eds). Amsterdam: Elsevier Science Publishers, 1991: 159-68.
46.
Huang YP, Perrin LH, Miescher PA, Zubler RHCorrelation of T and B cell activities in vitro and serum IL-2 levels in systemic lupus erythematosus. J Immunol1988; 141: 827-33.
47.
Vidaller A. , Llorente L., Larrea F., Mendez JP, Alcocer-Varela J, Alarcon-Segovia D. T cell dysregulation in patients with hyperprolactinemia: effect of bromocriptine treatment. Clin Immunol Immunopathol1986; 38: 337-43.
48.
Pauzner R., Urowitz MB, Gladman DDProlactin levels in systemic lupus erythematosus. Arthritis Rheum1992; 35: S239 (abstract D156).
Sabharwal P. , Glaser R., Lafuse W. et al. Prolactin synthesized and secreted by human peripheral blood mononuclear cells: an autocrine growth factor for lymphoproliferation. Proc Natl Acad Sci USA1992; 89: 7713-16.
52.
Yamaguchi M. , Koike K., Yoshimoto Y., Ikegami H., Miyake A., Tanizawa O.Effect of TNF-α on prolactin secretion from rat anterior pituitary and dopamine release from the hypothalamus: comparison with the effect of interleukin-1 beta. Endocrinol Jpn1991; 38: 357-61.
53.
Beach JE, Smallridge RC, Kinzer CA, Bernton EW, Holaday JW, Fein HGRapid release of multiple hormones from rat pituitaries perifused with recombinant interleukin-1. Life Sci1989; 44: 1-7.
54.
Karanth S., McCann SM. Anterior pituitary hormone control by interleukin 2. Proc Natl Acad Sci Sci USA1991; 88: 2961-5.
55.
Yamaguchi M. , Koike K., Matsuzaki N. et al. The interferon family stimulates the secretion of prolactin and interleukin-6 by the pituitary gland in vitro. J Endocrinol Invest1991; 14, 457-61.
Webster EL, Tracey DE, De Souza EBUpregulation of interleukin-1 receptors in mouse AtT-20 pituitary tumor cells following treatment with corticotropin-releasing factor. Endocrinology1991; 129: 2796-8.
58.
Arzt E., Buric R., Stelzer G. et al. Interleukin involvement in anterior pituitary cell growth regulation: effects of IL-2 and IL-6. Endocrinology1993 ; 132: 459-67.
59.
Ohmichi M., Hirota K., Koike K. et al. Binding sites for interleukin-6 in the anterior pituitary gland . Neuroendocrinology1992; 55: 199-203.
60.
Al-Janadi M. , Al-Bella S., Al-Dalaan A., Raziuddin S.Cytokine production in systemic lupus erythematosus and other rheumatic diseases. Arthritis Rheum1992; 35: S305 (abstract PO125).
61.
Al-Janadi M. , Al-Balla S., Al-Dalaan A., Raziuddin S.Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis and other rheumatic diseases. J Clin Immunol1993; 13: 58-67.
62.
Linker-Israeli M., Deans RJ, Wallace DJ, Prehn J., Ozeri-Cheh T., Klinenberg JRElevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J Immunol1991; 147: 117-23.
63.
Hirohata S. , Miyamoto T.Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement. Arthritis Rheum1990; 33: 644-9.
64.
Jara LJ, Zazueta B., Irigoyen L., Ortiz M., Bravo G., Fraga A.Prolactin (PRL) and interleukin 6 (IL-6) in the cerebrospinal fluid (CSF) of patients with systemic lupus erythematosus and central nervous system involvement (CNS-SLE). Arthritis Rheum1993; 36: S88 (abstract 296).
Parra A., Alarcon J., Gavino F., Ramirez A., Espinosa de los Monteros A. Age-related changes in the metoclopramide-induced prolactin release in nulliparous women. Fertil Steril1993; 60: 34-9.
67.
Rabinovich CE, Schanberg LE, Kredich DWIntravenous immunoglobulin and bromocriptine in the treatment of refractory neuropsychiatric systemic lupus erythematosus . Arthritis Rheum1990; 33 (Suppl.): R22 (abstract 49S).
68.
Liang MH, Socher SA, Larson MG, Schur PHReliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum1989; 32: 1107-18.
69.
Bombardier C., Gladman DD, Urowitz MB, Caron D., Chang CHDerivation of the SLEDAI. A disease activity index for lupus patients. Committee on Prognosis Studies in SLE. Arthritis Rheum1992; 35: 630-40.